Filing Details
- Accession Number:
- 0001731122-24-000828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-17 06:01:00
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-17 06:01:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1314052 | Anavex Life Sciences Corp. | AVXL | Biological Products, (No Disgnostic Substances) (2836) | 980608404 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1646396 | Steffen Thomas | 630 5Th Avenue, 20Th Floor New York NY 10111 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-15 | 5,000 | $4.52 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Purchase price denominated in Euros has been translated to US dollars using an exchange rate of 0.92
Billionaire Hedge Funds
